Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries

by Melissa J. Barber, Dzintars Gotham, Giten Khwairakpam, Andrew Hill
Published 2020-09-01

The hepatitis C treatment revolution: how to avoid Asia missing out

by Nick Walsh, Nicolas Durier, Giten Khwairakpam, Annette H. Sohn, Ying-Ru Lo
Published 2015-10-01

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals

by Andrew Hill, Loai Tahat, Mohammed Khalil Mohammed, R.abab Fayez Tayyem, Giten Khwairakpam, Sanjay Nath, James Freeman, Ismahane Benbitour, Sherine Helmy
Published 2018-04-01

High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C

by Andrew Hill, Giten Khwairakpam, James Wang, Sergey Golovin, Julia Dragunova, Rachel Smith, Vicky Houghton-Price, Roxanna Korologou-Linden, Sanjay Nath, Anna Savage, Greg Jefferys
Published 2017-10-01

The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing

by Joseph D. Tucker, Kathrine Meyers, John Best, Karyn Kaplan, Razia Pendse, Kevin A. Fenton, Isabelle Andrieux-Meyer, Carmen Figueroa, Pedro Goicochea, Charles Gore, Azumi Ishizaki, Giten Khwairakpam, Veronica Miller, Antons Mozalevskis, Michael Ninburg, Ponsiano Ocama, Rosanna Peeling, Nick Walsh, Massimo G. Colombo, Philippa Easterbrook
Published 2017-11-01